be_ixf;ym_202111 d_28; ct_50
Loading Events

« All Events

  • This event has passed.

Immunotherapy for Internists and Emergency Medicine Providers

January 27

Click Here to Access OnDemand Recording 

Click Here to Access CME Evaluation

 Immunotherapy for Internists and Emergency Medicine Providers

Presented By: Nabil Saad, MD – Hematology Oncology

Learning Objectives:

  • Overview about novel immunotherapy treatments
  • Expected side effects of immunotherapy and their managements
  • Quick look at other targeted therapies

Dr. Saad thinks of himself as a coach for patients as they fight against the disease they’re battling. However, he views everyone involved as a team member, with the patient being the main player.”I love getting to know someone’s potential and values” Dr. Saad said. “Throughout the process, I learn what someone can and can’t do, what they would and wouldn’t do, and I get to see where they’re coming from, while holding their hands to reach their goals. Communication is key.”Dr. Saad stresses that any achievement is huge when you’re fighting against cancer, and he tries to celebrate these moments with patients. “It is time to live beyond cancer.” Outside of his time working with patients, you can often find Dr. Saad drawing, outdoors, playing soccer, or hiking. Dr. Saad is American Board certified in Medical Oncology, Hematology and Internal Medicine.


Accreditation Statement: The Beacon Health System is accredited by the Indiana State Medical Association to provide continuing medical education for physicians.

Designation Statement: Beacon Health System designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure: Physician(s) and all planners associated with this activity do not have any potential conflict of interest.

Disclosure Statement: As a CME provider accredited by the Indiana State Medical Association, Beacon Health System must ensure balance, independence, objectivity, and scientific rigor in all sponsored educational programs. All faculty participating in these programs must complete a disclosure statement indicating any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains to relationships with pharmaceutical companies, biomedical device manufactures, or other corporations whose products or services are related to the subject matter of the presentation topic.

Commercial Support: No commercial support was used in planning or implementation of the CME activity.

On Demand Details: Recordings are available for credit until 1/27/2022

Questions may be directed to Jenai White at 574.647.7691 or


January 27
Event Categories:
, ,